WHO ICTRP trial
Phase III clinical trial of DP-R206 and Bonvia In postmenopausal women with…
KCT0000415 · Clinical Research Information Service (CRIS) · Recruiting
Key facts
| Trial ID | KCT0000415 |
|---|---|
| Public title | Phase III clinical trial of DP-R206 and Bonvia In postmenopausal women with Osteoporosis |
| Scientific title | A multicenter, randomized, double-blind, active-controlled, phase III clinical trial to evaluate the efficacy and safety of DP-R206 and Bonvia for the improvement of Vitamin D In postmenopausal women with Osteoporosis ; DIOS study |
| Primary sponsor | Dream Pharma |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Recruiting |
| Study type | Interventional Study |
| Phase | Phase3 |
| Countries | Korea, Republic of |
| Conditions | Diseases of the musculo-skeletal system and connective tissue |
| Interventions | Drug : Test drug : DP-R206 (ibandroante 150mg + cholecalciferol 24,000IU) reference drug : Bonviva tablet (ibandronate 150 mg) Once a month, oral administration for 16weeks Test group : Once a month, administration of DP-R206 & placebo for… |
| Registration date | Apr 24, 2012 |
| Target size | 204 |
| Secondary IDs | NCT01581320 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: